Literature DB >> 6096308

In vitro studies on the mechanism of adherence and pathogenicity of mycoplasmas.

I Kahane.   

Abstract

Most pathogenic mycoplasmas adhere to the cytoplasmic membrane of host cells in an avid, almost irreversible way. This interaction seems hydrophobic in nature and may be induced in the area of contact when the surface proteins are cleared away by electrostatic forces. In several mycoplasmas (e.g., Mycoplasma pneumoniae, M. gallisepticum and M. genitalium) the initial steps of adherence are reversible interactions occurring between mycoplasma adhesins that recognize specific sialoglycoconjugates on the host cell membrane. In M. pneumoniae the major adhesin (P1) is an integral membrane protein of about 165 kDa. About 10% of the P1 molecules are linked to the cytoskeleton elements. Part of the proteins in these cytoskeletal elements are phosphorylated, which may explain the anchorage and possible mobilization of P1 to the tip structure, as was indicated by immunohistochemical electron microscopy. With the close contact caused by attachment of the mycoplasmas to the host cells, their pathogenicity can be expressed. Studies with M. pneumoniae on a variety of human cells in culture indicated that superoxide anions are generated during the infection. They drastically inhibit the catalase activity of the host cells. Addition of exogenous superoxide dismutase or increasing its level endogenously minimize the inhibition of catalase. With much of the catalase inhibited, oxidation of cell components occurs, among which are membrane lipids as indicated by elevated malonyldialdehyde levels in infected cells. These may lead to membrane leakage and to the cytopathology of mycoplasma infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096308

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  6 in total

1.  Adherence of Ureaplasma urealyticum to human erythrocytes.

Authors:  A B Saada; Y Terespolski; A Adoni; I Kahane
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

2.  Frontiers in mycoplasma pathogenicity.

Authors:  I Kahane
Journal:  World J Microbiol Biotechnol       Date:  1992-12       Impact factor: 3.312

3.  Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae.

Authors:  M Almagor; I Kahane; C Gilon; S Yatziv
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 4.  The Immunopathogenesis of Mycoplasma genitalium Infections in Women: A Narrative Review.

Authors:  Patricia M Dehon; Chris L McGowin
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

Review 5.  Pathogenesis and Treatment of Neurologic Diseases Associated With Mycoplasma pneumoniae Infection.

Authors:  Renato D'Alonzo; Elisabetta Mencaroni; Lorenza Di Genova; Daniela Laino; Nicola Principi; Susanna Esposito
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

6.  Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo.

Authors:  Victoria Garrido; Carlos Piñero-Lambea; Irene Rodriguez-Arce; Bernhard Paetzold; Tony Ferrar; Marc Weber; Eva Garcia-Ramallo; Carolina Gallo; María Collantes; Iván Peñuelas; Luis Serrano; María-Jesús Grilló; María Lluch-Senar
Journal:  Mol Syst Biol       Date:  2021-10       Impact factor: 11.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.